Download the ICS Branding Pack
Podium Short Oral Session 23 Pelvic Organ Prolapse 454 A randomized controlled trial: laparoscopic and robotic assisted laparoscopic sacrocolpopexy, long term outcomes
Podium Short Oral Session 30 Epidemiology and Prevention 619 Urinary tract infection still a challenge to fight: a real setting study
Open Discussion ePoster Session 19 Open Discussion ePosters 2 384 Could the transperineal ultrasound predict the trans-obturator midurethral sling failure?
Podium Short Oral Session 30 Female Lower Urinary Tract Symptoms 2 532 Laparoscopic and robotic assisted laparoscopic sacrocolpopexy: a randomized controlled trial in the era of minimally invasive surgery
Podium Short Oral Session 36 Female Lower Urinary Tract Symptoms and Neurourology 716 Trans-vaginal urethrolysis for the treatment of iatrogenic female urethral obstruction: surgery outcome and risk factors
Podium Short Oral Session 36 Female Lower Urinary Tract Symptoms and Neurourology 717 Can the laparoscopic sacrocolpopexy improve the preoperative urinary dysfunctions?: urodynamic findings and functional outcomes after surgery for severe pelvic organ prolapse
Non Discussion Abstract Session 41 Non Discussion Abstracts 826 Wait and see: is it a possible option in asymptomatic patients with mesh exposure?
Open Discussion ePoster Session 19 Open Discussion ePosters 299 Coital incontinence: prevalence and risk factors in incontinent women
Open Discussion ePoster Session 19 Open Discussion ePosters 301 Childhood urinary symptoms: do they “predict” urinary problems in young adult women?
Podium Short Oral Session 20 Surgery for Pelvic Organ Prolapse 377 Abdominal vs laparoscopic sacrocolpopexy: subgroup analysis of a prospective randomized trial
Podium Short Oral Session 20 Surgery for Pelvic Organ Prolapse 383 Polyvinylidenfluorid (PVDF) versus Polypropylene mesh for sacrocolpopexy
Non Discussion Video Session 31 Non Discussion Videos 589 Readjustable sling procedure (Remeex System) for the treatment of female and male urinary incontinence: the readjustability advantage
Non Discussion Video Session 31 Non Discussion Videos 598 Sacrocolpopexy is always up-to-date: robotic-assisted and uterus- sparing
Non Discussion Abstract Session 32 Non Discussion Abstracts 857 Mirabegron: medication adherence, patient satisfaction and improvement of quality of life in women with OAB
Podium Short Oral Session 23 Female Lower Urinary Tract Symptoms 297 Urological dysfunctions in young women.” Is it an inheritance of childhood? "
Podium Short Oral Session 30 Pelvic Organ Prolapse 451 Long term outcomes following abdominal sacral colpopexy for vaginal vault prolapse
Podium Short Oral Session 30 Pelvic Organ Prolapse 452 Long term outcomes following abdominal sacral colpopexy with uterus preservation
Podium Short Oral Session 35 Female Stress Urinary Incontinence 500 Has detrusor underactivity a role on the outcomes after trans-obturator mid-urethral sling? A prospective observational study
Podium Short Oral Session 35 Female Stress Urinary Incontinence 502 Trans-obturator mid-urethral sling in female mixed urinary incontinence
Ester Illiano declared on the Saturday 27th April 2019 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
ICS Terminology Discussions Group